Dr Brian Stickle

1
Acute Pain
Physiology And Pharmacology

• Dr Brian Stickle
• Consultant Anaesthetist
• Acute Pain Team
• Department of Anaesthesia
• ARI

2
Contents

• Physiology of Pain
• Recap
• Pharmacology
• Opiates
• NSAIDs (inc paracetamol)
• Tramadol
• Multi-modal analgesia
• Routes of drug delivery

3
Definition
Pain is an unpleasant sensory and emotional
experience associated with actual or potential
tissue damage or described in terms of such
damage.

• International Association for the Study of Pain
• Implies emotional component.
• Pain can exist without tissue damage.

4
Acute Pain

• Nociceptive pain.
• Derived directly from pain receptors.
• Arises in damaged tissues.
• Sensed in damaged area.
• Has a cause which is of finite duration.
• Has a Purpose.

5
Aetiology of Acute Pain 1
6
Aetiology of Acute Pain 2
7
Aetiology of Acute Pain 3
8
Aetiology of Acute Pain 4
9
(No Transcript)
10
Peripheral Generation of Pain

• Tissue damage
• Increased blood vessel permeability
• Swelling / Oedema
• Vasodilation
• Redness
• Stimulated inflammatory process
• Immune response white cell activation
• Phagocytosis
• Sensitisation of nerve endings
• Tenderness

11
Peripheral Generation of Pain
Tissue injury
Blood Vessel
Tissue
K
H
PGs, leukotrienes
Oedema
Plasma extravasation
Nerve terminal
Bradykinin
SP NKA CGRP
Mast cell
Spinal cord
Histamine
5HT
platelet
12
Spinal ModulationGate Control Theory
opiate receptors
Central control
Gate control System
-

Fast fibres touch / pressure

Action System
T
PAIN
SG
-

Slow pain fibres

-

13
Descending control

• Sensory System
• descending inhibitory systems
• stop pain transmission
• loss of inhibition pain
• transmission noradrenaline, 5HT

14
Descending control
Midbrain
Periaqueductal grey


Locus coeruleus
Pons
Medulla
Raphe magnus


Spinal cord
5-HT
Noradrenaline
opiate receptors

15
Analgesic Drugs
Nerve Endings
Peripheral Nerves
Plexuss
Nerve Roots
Cord
Brainstem
Brain
16
NSAIDs

• Non Steroidal Anti-Inflammatory Drugs
• willow bark - salicin
• Cyclo-oxygenase inhibitors
• Sole therapy for mild/moderate pain
• Combination therapy as part of Multi-modal
  analgesia

17
COX inhibition and NSAIDs
Two Isoforms of Cyclo-oxygenase
Cyclo-oxygenase (COX)
COX - 1 Constitutive COX Lung, Gut, Kidney,
Platelets
COX - 2 Inducible COX All inflamed / damaged
tissues

• ? Most likely mechanism for NSAID-mediated
  analgesia.
• Selective COX-2 inhibitors should produce
  analgesia with fewer adverse effects.

18
NSAID Side effects

• Renal
• removes vasodilatory prostaglandins
• precipitate ARF in susceptible Patients
• impaired renal blood flow
• dehydration
• impaired renal function
• other nephrotoxic therapies

• Respiratory
• aspirin sensitive asthma
• GI
• peptic ulceration stomach duodenum
• Platelets
• reduces stickiness
• increased bleeding

All COX-1
19
Paracetamol

• The most under-rated drug in the BNF
• Stickle, B.R. 1996 (and loads of times since)
• Inhibits central COX
• BUT - role of central COX unclear
• Analgesic
• Antipyretic
• No peripheral effects
• No toxicity in therapeutic doses (?)

20
Opiates Sites of action

• Central
• PAGM - role in descending control
• Spinal
• Gating function Inhibits release of
  neurotransmitters involved in pain transmission
• Peripheral
• receptors only active in inflammatory states

21
Opiate Side Effects

• Respiratory depression
• antagonised by pain
• all opiates the same at equianalgesic doses
• risk small if properly titrated
• CNS
• sedation, euphoria, dysphoria, NV, miosis
• GU/GI
• urinary retention, decreased GI motility, spasm
  of sphincter of Oddi

22
Tramadol

• Weak µ agonist (1/6000 v morphine)
• selective µ agonist
• pure agonist activity
• 30 of effect antagonised by naloxone
• Noradrenaline reuptake inhibitor
• 5-HT reuptake inhibitor
• Non-controlled drug

23
Tramadol Descending control
24
Tramadol

• Advantages
• relative lack of respiratory depression
• less sedative vs morphine
• ?? less N V
• less GI SFX
• non-controlled drug
• oral preparation effective
• Disadvantages
• slightly less potent vs morphine
• slower onset times
• cost

25
(No Transcript)
26
Ketamine

• NMDA receptor antagonist
• NMDA receptors shown to have role in development
  of hyperalgesia
• Blockade of NMDA receptors may prevent
  development of opioid tolerance
• Established opioid sparing effect

27
Ketamine

• General anaesthetic agent
• Doses typically 1-2mg/kg
• Atypical
• Preserves CVS / resp function
• Airway reflexes / patency generally preserved
• Analgesic
• Bronchodilator
• Famous side effects
• Hallucinations

28
Ketamine

• Analgesic at low doses
• 10 of anaesthetic doses
• LOADS of studies
• Cochrane review
• It works
• 30-50 reduction in opiate doses
• Reduced PONV

29
Ketamine

• How to give it?
• Single dose ?
• Continuous infusion ?
• Added to PCA X
• Epidurally ? ?

30
Ketamine Side effects?

• Doses low
• Tolerability good in all trials
• Reduced PONV pruritis
• Some increased sedation
• Low incidents of hallucination / vivid dreaming

31
Ketamine

• Proven adjuvant in opioid tolerance in chronic
  and cancer pain
• Poorly studied in acute pain
• But
• Significant reduction in opioid requirements in
  positive studies
• Anecdotally effective

32
Multi-Modal Analgesia

• Concept of combination therapy
• Advantages
• Reduction in SFX
• minimising doses, synergy
• IMPROVED ANALGESIA
• Disadvantages
• Multiplication of SFX
• Cost
• Polypharmacy

33
Multi-Modal Analgesia
Nerve Endings
Peripheral Nerves
Plexuss
Nerve Roots
Cord
Brainstem
Brain
34
Multi-Modal Analgesia
35
Multi-Modal Analgesia The Rules

• Give REGULAR background analgesia
• Paracetamol / NSAID
• On the clock
• Give as required opiate
• Dose / strength dependant on pain problem
• Review

36
Multi-Modal Analgesia ?
Opiate
As required
Plus
(maybe)
37
Multi-Modal Analgesia - really
NSAID Paracetamol
Regularly
And
As required opiate
38
Modes of delivery

• Regular(bd, tds, qds)
• PRN
• (Patient receives NONE)
• Slow release
• Infusion
• PCA
• IV, Epidural

39
Routes of delivery

• Oral
• Rectal
• Subcutaneous
• Transdermal
• Intramuscular
• Intravenous
• Epidural
• Intra-spinal

40
IM / SC Morphine
Effective Plasma Concentration
Morphine concentration
3 hours
Time
41
Intermittent subcut / IM
42
PCA Morphine
Effective Plasma Concentration
Morphine concentration
Time
bolus 1mg
43
Sustained release oral opiate
Effective Plasma Concentration
Plasma morphine concentration
4
8
12
Time
44
Sustained release supplement
Effective Plasma Concentration
Plasma morphine concentration
4
8
12
Time
45
?
46
Summary

• Pain pathway vulnerable at a number of points
• Peripheral sensitisation primary problem
• Transmission can be modulated spinally and
  centrally
• Combination therapy
• Maximises analgesia
• Minimises side effects

47
(No Transcript)
48
Local Anaesthesia and Epidural Blocks
49
Analgesic Drugs
Nerve Endings
Peripheral Nerves
Plexuss
Nerve Roots
Cord
Brainstem
Brain
50
Local Anaesthetics

• Lignocaine, bupivacaine, prilocaine.
• Sodium channel blockers
• Pharmacologically filthy !!!
• Prevent propagation of action potential
• LA molecules must pass into axon to block sodium
  channel from within.

51
Local anaesthetics
Na
depolarisation
Na
un-ionised ionised
52
LA Differential Blockade

• Due to differential penetration into different
  nerve types
• Myelinated, thick fibres Relatively spared
• Motor fibres spared (relatively)
• Pain fibres blocked easily (luckily)

53
Local anaesthetics

• Limiting factor in use is toxicity
• Toxicity - high plasma levels
• Intravenous injection
• Absorption gt rate of metabolism high plasma
  levels
• \ vasoconstrictors - reduce blood flow, reduce
  absorption.
• Toxicity depends on-
• dose used
• rate of absorption
• patient weight
• drug ( bupivacaine gt lignocaine gt prilocaine )

54
Regional local anaesthesia

• Retain awareness / consciousness
• Lack of global effects of systemic analgesics
• Derangement of CVS physiology
• proportional to size of anaesthetised area
• Relative sparing of respiratory function

55
Regional local anaesthesia

• Local anaesthesia
• Field blocks
• hernia repair
• Plexus blocks
• Limb blocks
• e.g. femoral N sciatic N
• Central neural (neuraxial) block
• epidural
• spinal

Increasing physiological impact
56
Neuraxial block
57
Postoperative epidural analgesia

• Proven benefit in certain groups of patients
• ? Proven benefit for certain ops
• High incidence of minor CVS side effects
• Low incidence of major CNS side effects
• Haematoma / abscess

58
Epidural advantages

• Gold standard analgesia
• Improved co-operation with physiotherapy /
  nursing staff
• Avoid systemic opiates
• Less sedation
• Less interference with resp function

59
Epidural opiates

• Act on spinal cord
• Improve quality of analgesia
• Relative lack of systemic effects
• But-
• Pruritis
• High incidence of respiratory depression when
  combined with systemic opiates.

60
Epidural infusions

• Short half life of LA / opiate in epidural space
  (3-4 hours)
• Repeated top ups
• less stable block
• breakthrough pain
• Infusion
• requires kit
• Rate can be variable (sliding scale)
• Tachyphlaxis

61
Physiology of neuraxial block CVS
Venodilation
MAP CO SVR
Arteriolar vasodilation
62
Signs and symptoms of local anaesthetic toxicity

• Circumoral and lingual numbness and tingling
• Light-headedness
• Tinnitus, visual disturbances
• Muscular twitching
• Drowsiness
• Cardiovascular depression
• Convulsions
• Coma
• Cardiorespiratory arrest

63
(No Transcript)
64
Scenario 1

• 26 y/o asthmatic man
• Appx. Given IM Morphine 10mg 4 hourly. Pain
  scores 3-4

65
Scenario 2

• 80 y/o lady. No sig PMH.
• Hemiarthroplasty. No analgesia prescribed.
  Spinal anaesthetic wearing off. Not PU'd.

66
Scenario 3

• 56 y/o man. Metastatic lung Ca.
• Pathological femur. IM Nail
• Normally has MXL 150mg

67
Scenario 4

• 75 y/o lady. L hemi-colectomy.
• PCA Morphine. Sedated .
• Pain scores 3-4 (when awake !!)

68
Scenario 5

• 65 y/o lady. Longstanding pain in right hip.
• Takes paracetamol occasionally codeine 30mg
  prn.
• Pain worsening recently interfering with daily
  living